参考文献/References:
[1].Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study[J].Circulation,2014,129(8):837-847.
[2].Higa S,Lo LW.Catheter ablation of paroxysmal atrial fibrillation originating from non-pulmonary vein areas[J].Arrhythm Electrophysiol Rev,2018,7(4):273-281.
[3].Zaman JA.The rotor revolution: conduction at the eye of the storm in atrial fibrillation[J].Circ Arrhythmia Electrophysiol,2014,7(6):1230-1236.
[4].Begg GA,Holden AV,Lip GY,et al.Assessment of atrial fibrosis for the rhythm control of atrial fibrillation[J].Int J?Cardiol,2016,220:155-161.
[5].King JH,Huang CL.Determinants of myocardial conduction velocity: implications for arrhythmogenesis[J].Front Physiol,2013,4:154.
[6].Kléber AG.Basic mechanisms of cardiac impulse propagation and associated arrhythmias[J].Physiolog Rev,2004,84(2):431-488.
[7].Gaspo R,Bosch RF,Talajic M.Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model[J].Circulation,1997,96(11):4027-4035.
[8].Chen L,Li QY,Yang Y,et al.Inhibitory effects of tetrandrine on the Na(+) channel of human atrial fibrillation myocardium [J].Acta Pharmacol Sin,2009,30(2):166-174.
[9].Liu M,Yang KC.Cardiac sodium channel mutations:why so many phenotypes?[J].Curr Top Membr,2016,78:513-559.
[10].Dzeshka MS,Lip GY,Snezhitskiy V.Cardiac fibrosis in patients with atrial fibrillation:mechanisms and clinical implications[J].J Am Coll?Cardiol,2015,66(8):943-959.
[11].McDowell KS,Arevalo HJ,Maleckar MM.Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density[J].Biophys J,2011,101(6):1307-1315.
[12].Dhillon PS,Gray R,Kojodjojo P,et al.Relationship between gap-junctional conductance and conduction velocity in mammalian myocardium[J].Circ Arrhythmia Electrophysiol,2013,6(6):1208-1214.
[13].Nattel S.Atrial remodeling and atrial fibrillation: recent advances and translational perspectives[J].J Am Coll?Cardiol,2014,63(22):2335-2345.
[14].Wong CX,Stiles MK,John B,et al.Direction-dependent conduction in lone atrial fibrillation[J].Heart rhythm,2010,7(9):1192-1199.
[15].Grossi S,Grassi F,Galleani L,et al.Atrial conduction velocity correlates with frequency content of bipolar signal[J].Pacing Clin Electrophysiol:PACE,2016,39(8):814-821.
[16].Honarbakhsh S,Schilling RJ,Orini M,et al.Structural remodeling and conduction velocity dynamics in the human left atrium:relationship with reentrant mechanisms sustaining atrial fibrillation[J].Heart rhythm,2019,16(1):18-25.
[17].Kojodjojo P,Kanagaratnam P,Markides V,et al.Age-related changes in human left and right atrial conduction[J].J Cardiovasc Electrophysiol,2006,17(2):120-127.
[18].Kistler PM,Sanders P,Fynn SP,et al.Electrophysiologic and electroanatomic changes in the human atrium associated with age[J].J Am Coll?Cardiol,2004,44(1):109-116.
[19].Kumagai K,Akimitsu S,Kawahira K,et al.Electrophysiological properties in chronic lone atrial fibrillation[J].Circulation,1991,84(4):1662-1668.
[20].Konings KT,Kirchhof CJ,Smeets JR,et al.High-density mapping of electrically induced atrial fibrillation in humans[J].Circulation,1994,89(4):1665-1680.
[21].Zheng Y,Xia Y,Carlson J,et al.Atrial average conduction velocity in patients with and without paroxysmal atrial fibrillation[J].Clin Physiol Funct Imaging,2017,37(6):596-601.
[22].Platonov PG,Yuan S,Hertervig E,et al.Further evidence of localized posterior interatrial conduction delay in lone paroxysmal atrial fibrillation[J].Europace,2001,3(2):100-107.
[23].Xia Y,Hertervig E,Kongstad O,et al.Deterioration of interatrial conduction in patients with paroxysmal atrial fibrillation: electroanatomic mapping of the right atrium and coronary sinus[J].Heart rhythm,2004,1(5):548-553.
[24].Papageorgiou P,Monahan K,Boyle NG,et al.Site-dependent intra-atrial conduction delay Relationship to initiation of atrial fibrillation[J].Circulation,1996,94(3):384-389.
[25].MOE GK.Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge[J].Am Heart J,1959,58(1):59-70.
[26].Abildskov JA.Additions to the wavelet hypothesis of cardiac fibrillation[J].J Cardiovasc Electrophysiol,1994,5(6):553-559.
[27].Verheule S,Tuyls E,van Hunnik A,et al.Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation[J].Circ Arrhythmia Electrophysiol,2010,3(6):590-599.
[28].Lee G,Kumar S,Teh A,et al.Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity[J].Eur Heart J,2014,35(2):86-97.
[29].Cuculich PS,Wang Y,Lindsay BD,et al.Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns[J].Circulation,2010,122(14):1364-1372.
[30].Allessie MA,de Groot NM,Houben RP,et al.Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation[J].Circ Arrhythmia Electrophysiol,2010,3(6):606-615.
[31].Roberts-Thomson KC,Stevenson I,Kistler PM,et al.The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction[J].Heart rhythm,2009,6(8):1109-1117.
[32].de Groot NM,Houben RP,Smeets JL,et al.Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough[J].Circulation,2010,122(17):1674-1682.
[33].Eckstein J,Zeemering S,Linz D,et al.Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping[J].Circ Arrhythmia Electrophysiol,2013,6(2):334-341.
[34].Oakes RS,Badger TJ,Kholmovski EG,et al.Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation[J].Circulation,2009,119(13):1758-1767.
[35].Miyamoto K,Tsuchiya T,Narita S,et al.Bipolar electrogram amplitudes in the left atrium are related to local conduction velocity in patients with atrial fibrillation[J].Europace,2009,11(12):1597-1605.
[36].Koller ML,Maier SK,Gelzer AR,et al.Altered dynamics of action potential restitution and alternans in humans with structural heart disease[J].Circulation,2005,112(11):1542-1548.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(9):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(9):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(9):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(9):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(9):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]张佳圩 黄从新.预防心房纤维化对心房颤动患者射频消融术后复发的影响[J].心血管病学进展,2020,(1):89.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.024]
ZhANG Jiawei,HUANG Congxin.Prevention of Atrial Fibrosis Affects Atrial Fibrillation Recurrence after Radiofrequency Ablation[J].Advances in Cardiovascular Diseases,2020,(9):89.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.024]